Afficher la notice abrégée

dc.contributor.authorRoyal Pharmaceutical Society of Great Britain
dc.date.accessioned2015-01-06T23:08:49Z
dc.date.available2015-01-06T23:08:49Z
dc.date.issued2011
dc.identifier.citationLondon: Royal Pharmaceutical Society, 2011en_US
dc.identifier.isbn978085369 9620
dc.identifier.urihttp://hdl.handle.net/123456789/419
dc.description.abstractNobody working in healthcare can afford to be without the latest edition of the British National Formulary. Compiled with the advice of clinical experts and continually updated to reflect the latest evidence from all credible sources worldwide, this essential reference provides up-to-date guidance on prescribing, dispensing, administering, and monitoring medicines. Not only does the BNF include the widely accepted framework for the drug management of common diseases, it also includes details of medicines prescribed in the UK, with special reference to their uses, cautions, contraindications, side-effects, dosage and relative costs. This allows treatment to be tailored to the individual needs of each patient. The BNF is updated in print every six months by an expert team of pharmacists, with guidance and validation from a network of leading clinicians, overseen by a Joint Formulary Committee with representatives from all spheres of clinical practice. The BNF reflects current best practice as well as legal and professional guidelines relating to the use of medicines. As a result it is used widely as a touchstone reference, and cited in Parliaments and courts as a source of authority.en_US
dc.language.isoenen_US
dc.publisherRoyal Pharmaceutical Societyen_US
dc.subjectPharmacologyen_US
dc.subjectDrugsen_US
dc.subjectMedicineen_US
dc.titleBritish National Formulary 61en_US
dc.typeBooken_US


Fichier(s) constituant ce document

Thumbnail

Ce document figure dans la(les) collection(s) suivante(s)

Afficher la notice abrégée